Axela Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Axela Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011834
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and applications support, on-site and in-house training, extended warranty, service and maintenance contracts; and custom application development services. The company creates tools and content to simplify multiplex biomarker detection for translational research and diagnostic testing. It markets its products through a network of distributors in Canada, Ireland, Belgium, Luxemburg, Spain, the Netherlands, the UK and the US. Axela is headquartered in Toronto, Ontario, Canada.

Axela Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Axela Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axela Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axela Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axela Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Axela Inc, Medical Devices Deals, 2011 to YTD 2017 9
Axela Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Axela Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Into Technology Integration Agreement With Thermal Gradient 12
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 13
Asset Transactions 14
ANGLE Acquires Assets from Axela 14
Acquisition 15
Axela Mulls Offering Itself For Sale 15
Axela Inc – Key Competitors 16
Axela Inc – Key Employees 17
Axela Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Axela Inc, Pharmaceuticals & Healthcare, Key Facts 2
Axela Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axela Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axela Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axela Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Axela Inc, Medical Devices Deals, 2011 to YTD 2017 9
Axela Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Into Technology Integration Agreement With Thermal Gradient 12
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 13
ANGLE Acquires Assets from Axela 14
Axela Mulls Offering Itself For Sale 15
Axela Inc, Key Competitors 16
Axela Inc, Key Employees 17

★海外企業調査レポート[Axela Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mediolanum farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Mediolanum farmaceutici SpA (Mediolanum) is a healthcare solution provider that discovers, develops and markets pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, …
  • Royal BAM Group nv:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Royal BAM Group nv Mergers and …
  • Spineology Inc-医療機器分野:企業M&A・提携分析
    Summary Spineology Inc (Spineology) is a medical device company that develops and designs spinal implants. The company offers products such as pedicular fixation system, interbody fusion system, deployable grafting system, amniotic fixation system, allografts, retractor system, liquid tissue matrix, …
  • Imperial Holdings Limited:企業のM&A・提携・投資分析
    Imperial Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imperial Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Gamida Cell, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gamida Cell, Ltd. Mergers and A …
  • Societe Generale S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Societe Generale S.A. Mergers a …
  • GlobalSCAPE, Inc. (GSB):企業財務及び戦略的SWOT分析
    Summary GlobalSCAPE, Inc. (GlobalSCAPE) is a technology company that offers secure information exchange solutions. The company offers products such as managed file transfer, secure email, file replication and synchronization, secure FTP, and secure mobile file sharing. It offers services such as eme …
  • Emera (Caribbean) Incorporated (LPH):企業のM&A・提携動向(エネルギー分野)
    Summary Emera (Caribbean) Incorporated (EC), formerly Light & Power Holdings Ltd is an energy and service company. The company generates, distributes, and supplies electricity through its subsidiaries. It generates electricity from diesel, natural gas, hydroelectric power plants, solar photovoltaics …
  • Kadimastem Ltd (KDST):企業財務及び戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a biotechnology company that develops and commercializes stem cell-based therapeutics for diabetes and neurodegenerative disorders. The company offers human pluripotent stem cell technology, based on differentiation of human embryonic stem cells towards insulin …
  • Japan System Techniques Co., Ltd. (4323):企業概要、財務及び戦略的SWOT分析
    Summary Japan System Techniques Co., Ltd. (JST) is an information technology service provider. The company provides information technology solutions. It develops business applications, engineering applications and event applications; package business; system sales business; and medical big data busi …
  • West China Cement Limited:企業の戦略・SWOT・財務分析
    SummaryWest China Cement Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • ImmunoGen, Inc.:企業の戦略・SWOT・財務分析
    SummaryImmunoGen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • National Penn Bancshares, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' National Penn Bancshares, Inc. …
  • WGL Holdings, Inc. (WGL):企業の財務及び戦略的SWOT分析
    WGL Holdings, Inc. (WGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cleveland BioLabs, Inc. (CBLI):企業の財務及び戦略的SWOT分析
    Summary Cleveland BioLabs, Inc. (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product, entolimod, a recombinant protein which acts as an agonist of toll- …
  • Grieg Seafood ASA:企業の戦略・SWOT・財務分析
    SummaryGrieg Seafood ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • SPO Global Inc. (SPOM):企業の財務及び戦略的SWOT分析
    Summary SPO Global Inc. (SPO Global) is a medical device company that develops and manufactures vital sign monitoring devices. The company’s products include medical oximeters and personal oximeters. SPO Global offers personal oximeters for personal use, sports and general oxygen monitoring. The com …
  • Ryman Healthcare Ltd.の企業概要及び財務/SWOT分析
    Ryman Healthcare Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly …
  • Supreme Petrochem Ltd (SUPPETRO):企業概要、財務及び戦略的SWOT分析
    Summary Supreme Petrochem Ltd (SPL) is a chemical company. The company manufactures and sells polystyrene products. It offers products such as general purpose polystyrene, high impact polystyrene, master batches, specialty polystyrene and compound polystyrene. SPL’s high impact polystyrene covers ex …
  • Charter Hall Group:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Charter Hall Group" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follow …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆